85 related articles for article (PubMed ID: 3379335)
1. [A case of recurrent breast cancer for which NSE was a useful tumor marker].
Takise A; Takagi H; Abe T
Nihon Gan Chiryo Gakkai Shi; 1988 Jan; 23(1):79-83. PubMed ID: 3379335
[No Abstract] [Full Text] [Related]
2. [Clinical evaluation of several tumor markers in the chest surgery].
Miyazato I; Tojo N
Rinsho Kyobu Geka; 1988 Jun; 8(3):231-6. PubMed ID: 9301836
[No Abstract] [Full Text] [Related]
3. [A clinical study on neuron specific enolase (NSE) as a tumor marker in primary lung cancer].
Suzuki K; Reshad K; Takahashi Y; Morita H; Hirata T; Itoi K; Nakano Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Jun; 25(6):625-31. PubMed ID: 2824900
[No Abstract] [Full Text] [Related]
4. [Hyperamylasemia in endometrial adenocarcinoma].
Matsuta M; Murakami K; Ono H; Saitoh S; Nishiya I; Takayama K
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Oct; 41(10):1557-64. PubMed ID: 2479698
[TBL] [Abstract][Full Text] [Related]
5. [Creatine kinase BB and neuron specific r-enolase as biomarkers for lung cancer].
Usui A; Fujita K; Imaizumi M; Abe T; Inoue K; Matsumoto S; Kato K
Gan No Rinsho; 1987 Nov; 33(14):1763-70. PubMed ID: 2826840
[TBL] [Abstract][Full Text] [Related]
6. Reassessing tumor markers in local recurrences of breast cancer: a new insight.
Pedrini JL; Pedrini M; Savaris RF; Machado L; Grudzinski M; Zettler CG
Med Sci Monit; 2004 Dec; 10(12):BR462-7. PubMed ID: 15567977
[TBL] [Abstract][Full Text] [Related]
7. Is NSE truly a useful marker in NSCLC?
Ishikawa H; Satoh H; Sekizawa K
Lung Cancer; 2004 May; 44(2):267; author reply 269. PubMed ID: 15084392
[No Abstract] [Full Text] [Related]
8. [Tumor marker in lung cancer].
Shijubo N; Abe S
Kokyu To Junkan; 1993 Jun; 41(6):551-5. PubMed ID: 7687790
[No Abstract] [Full Text] [Related]
9. [Tumor markers in diagnosis of breast cancer].
Bartel U
Z Arztl Fortbild (Jena); 1991 Oct; 85(20):1015-21. PubMed ID: 1776283
[No Abstract] [Full Text] [Related]
10. [General and specific laboratory parameters within the scope of tumor after-care in gynecologic malignancies and breast cancer].
Kreienberg R
Gynakologe; 1989 Feb; 22(1):55-62. PubMed ID: 2653979
[No Abstract] [Full Text] [Related]
11. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases.
Schneider J; Philipp M; Velcovsky HG; Morr H; Katz N
Anticancer Res; 2003; 23(2A):885-93. PubMed ID: 12820318
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic value of pleural effusion carcinoembryonic antigen, squamous cell carcinoma related antigen and neuron-specific-enolase in patients with lung cancer].
Fujii M; Kiura K; Kamei H; Segawa Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1988 May; 26(5):519-23. PubMed ID: 2852270
[No Abstract] [Full Text] [Related]
13. [Tumor markers. II. Their significance in the follow-up of patients after radical resection of lung neoplasms].
Ratto GB; Capponi G; De Grandi R; Augeri C; Secco GB; Fardelli R
Minerva Chir; 1990 Oct; 45(20):1273-80. PubMed ID: 2082204
[TBL] [Abstract][Full Text] [Related]
14. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients.
Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E
Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320
[TBL] [Abstract][Full Text] [Related]
15. Classifying "recurrent" breast cancer: lost heterozygosity found.
Hameed O; Pfeifer JD
Am J Clin Pathol; 2005 May; 123(5):641-3. PubMed ID: 15981802
[No Abstract] [Full Text] [Related]
16. [Tumor markers. I. Their significance in the preoperative assessment of lung neoplasms].
Ratto GB; Capponi G; De Grandi R; Augeri C; Secco GB; Fardelli R
Minerva Chir; 1990 Oct; 45(20):1265-72. PubMed ID: 1964495
[TBL] [Abstract][Full Text] [Related]
17. [Possibilities and goals in after care of breast cancer].
Seifert M; Adler A; Obermair A; Hartmann B; Denison U; Kubista E; Sevelda P
Gynakol Rundsch; 1991; 31 Suppl 2():309-11. PubMed ID: 1665141
[No Abstract] [Full Text] [Related]
18. [Preliminary experience with BCM-IMx as a pretreatment marker of breast tumors].
Fernández Llana B; Fernández Fernández M; Suárez B; Allende MT
Rev Clin Esp; 1992 Mar; 190(4):209. PubMed ID: 1589619
[No Abstract] [Full Text] [Related]
19. [Study on carbohydrate antigen NCC-ST-439 in breast cancer].
Suzuki S; Nihei M; Nomizu T; Watanabe T; Kimijima I; Tsuchiya A; Abe R
Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):1019-26. PubMed ID: 2202768
[TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of serum neuron-specific enolase as a tumor marker in lung cancer].
Yonei T; Ohnoshi T; Hiraki S; Yamashita H; Ishii J; Egawa T; Kozuka A; Moritaka T; Uji H; Yoshida M
Nihon Kyobu Shikkan Gakkai Zasshi; 1988 Feb; 26(2):139-44. PubMed ID: 2841525
[No Abstract] [Full Text] [Related]
[Next] [New Search]
